Treace Medical Concepts, Inc. announced its preliminary, unaudited revenue for the fourth quarter and full-year of 2025.
Preliminary revenue for the fourth quarter was approximately $62.1 million to $62.5 million, showing a 9% decrease over the same period in 2024.
Full-year revenue for 2025 was approximately $212.3 million to $212.7 million, representing a 2% increase compared to the prior year.
Surgeon Adoption Growth
Active surgeon additions of approximately 202 for 2025 with a total of 3,337 active surgeons, showcasing a 6% increase over the previous year.
Bunion Technology Progress
The expanded suite of 3D bunion technologies drove mid-single-digit case volume growth in the fourth quarter, indicating positive progress.
Market Positioning
Treace maintains a leading position in the bunion market and focuses on expanding its surgeon customer base to increase its share of the bunion procedure market.
- Despite a decrease in revenue in the fourth quarter of 2025, Treace remains encouraged by surgeon adoption of advanced bunion technologies, leading to growth in case volumes.
- The Company's dedication to bunion-focused sales and market positioning strategies supports its goal of expanding in the bunion market and enhancing long-term shareholder value.
With positive trends in surgeon adoption and market positioning, Treace Medical Concepts, Inc. is poised for continued growth and market expansion in the bunion surgery field.